Avalo Therapeutics (AVTX) Shares Outstanding (Entity) (2014 - 2026)
Avalo Therapeutics (AVTX) Shares Outstanding (Entity) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 139.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.54 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 214.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 113.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 575.47 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.73 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - | 43.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.60 Mn |
| Mar 31, 2026 | 20.11 Mn |
| Dec 31, 2025 | 13.40 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 10.84 Mn |
| Mar 31, 2025 | 10.83 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 5.55 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 859,381.00 |
| Dec 31, 2023 | 277,727.00 |
| Sep 30, 2023 | 195,006.00 |
| Jun 30, 2023 | 58,534.00 |
| Mar 31, 2023 | 55,046.00 |
| Dec 31, 2022 | 39,325.00 |
| Sep 30, 2022 | 1.00 |
| Jun 30, 2022 | 39,222.00 |
| Mar 31, 2022 | 583.00 |
| Dec 31, 2021 | 583.00 |
| Sep 30, 2021 | 39,029.00 |